Interaction of 1,4-Dihydroxy-9,10-Anthraquinone with Calf Thymus DNA: A Comparison with Anthracycline Anticancer Drugs

被引：27

作者：

Guin, Partha Sarathi ^{[1
,2
]}

Das, Saurabh ^{[2
]}

Mandal, Parikshit Chandra ^{[1
]}

机构：

[1] Saha Inst Nucl Phys, Div Chem Sci, Kolkata 700064, India

[2] Jadavpur Univ, Dept Chem, Kolkata 700032, India

来源：

JOURNAL OF SOLUTION CHEMISTRY | 2011年 / 40卷 / 03期

关键词：

QH(2); Calf thymus DNA; UV-Visible spectroscopy; Fluorescence; Binding constant; Binding site size; CHROMOMYCIN A(3); ADRIAMYCIN; ANTIBIOTICS; COMPLEXES; BINDING; CARDIOTOXICITY; INTERCALATION; DAUNORUBICIN; MITHRAMYCIN;

D O I：

10.1007/s10953-011-9654-x

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

The anthracycline drugs adriamycin and daunorubicin, efficient in the treatment of various human cancers, form strong intercalation complexes with DNA. The therapeutic efficacy and toxicity of such anticancer drugs are governed by biochemical reactions of the core dihydroxy-9,10-anthraquinone unit. The high cost and toxic side effects of anthracycline drugs limit their use in cancer therapy. For a few decades, efforts have been made to find cheap, less toxic yet efficient analogues of anthracyclines. This work on 1,4-dihydroxy-9,10-anthraquinone (QH(2)), a simple analogue of the anthracyclines, was carried out to compare its biochemical properties with anthracyclines. UV-Vis and fluorescence spectroscopic methods were used to analyze interaction of the compound with calf thymus DNA. The data were used to evaluate the binding constant and site size.

引用

页码：492 / 501

页数：10

共 29 条

[1] A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy [J].

Abraham, R ;

Basser, RL ;

Green, MD .

DRUG SAFETY, 1996, 15 (06) :406-429

[2]

[Anonymous], 1999, PRINCIPLES FLUORESCE, DOI DOI 10.1007/978-1-4757-3061-6

[3] Structural effects of nogalamycin, an antibiotic antitumour agent, on DNA [J].

Banerjee, T. ;

Mukhopadhyay, R. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 374 (02) :264-268

[4] IRON(III) ADRIAMYCIN AND IRON(III) DAUNORUBICIN COMPLEXES - PHYSICOCHEMICAL CHARACTERISTICS, INTERACTION WITH DNA, AND ANTITUMOR-ACTIVITY [J].

BERALDO, H ;

GARNIERSUILLEROT, A ;

TOSI, L ;

LAVELLE, F .

BIOCHEMISTRY, 1985, 24 (02) :284-289

[5]

Cantor C., 1980, Biophysical Chemistry, V2

[6] Interaction of mithramycin and chromomycin A3 with d(TAGCTAGCTA)2:: Role of sugars in antibiotic-DNA recognition [J].

Chakrabarti, S ;

Bhattacharyya, B ;

Dasgupta, D .

JOURNAL OF PHYSICAL CHEMISTRY B, 2002, 106 (27) :6947-6953

[7] RESONANCE RAMAN-SPECTROSCOPIC STUDIES OF ADRIAMYCIN AND COPPER(II) ADRIAMYCIN AND COPPER(II) ADRIAMYCIN DNA COMPLEXES [J].

DUTTA, PK ;

HUTT, JA .

BIOCHEMISTRY, 1986, 25 (03) :691-695

[8] ANTHRACYCLINE DNA INTERACTIONS STUDIED WITH LINEAR DICHROISM AND FLUORESCENCE SPECTROSCOPY [J].

ERIKSSON, M ;

NORDEN, B ;

ERIKSSON, S .

BIOCHEMISTRY, 1988, 27 (21) :8144-8151

[9]

FERRANS VJ, 1978, CANCER TREAT REP, V62, P955

[10] COMPARISON OF THE BINDING OF ANTHRACYCLINE DERIVATIVES TO PURIFIED DNA AND TO CELL-NUCLEI [J].

FREZARD, F ;

GARNIERSUILLEROT, A .

BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1036 (02) :121-127

← 1 2 3 →